Skip to Content

Bromday Approval History

  • FDA approved: Yes (First approved October 16th, 2010)
  • Brand name: Bromday
  • Generic name: bromfenac
  • Dosage form: Ophthalmic Solution
  • Previous name: XiDay
  • Company: ISTA Pharmaceuticals, Inc.
  • Treatment for: Postoperative Ocular Inflammation

Bromday (bromfenac ophthalmic solution) is a once-daily ocular nonsteroidal anti-inflammatory agent for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.

Development History and FDA Approval Process for Bromday

Oct 20, 2010Approval ISTA Pharmaceuticals Receives FDA Approval for Bromday
Mar  9, 2010ISTA Pharmaceuticals Receives Action Date for FDA Review of Once-Daily XiDay
Dec 23, 2009ISTA Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Once-Daily XiDay

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.